Developing MPN Research: New Therapies for ET, PV, and Myelofibrosis

What are the latest research advances for essential thrombocytosis (ET), polycythemia vera (PV), and myelofibrosis (MF)? Myeloproliferative neoplasm (MPN) expert Dr. Shivani Handa reviews emerging therapies and innovative research that is opening the door to more effective, potentially disease-modifying treatments.

Dr. Shivani Handa is a hematologist-oncologist at the Ohio State University Comprehensive Cancer Center. Dr. Handa specializes in myeloid malignancies, which includes myeloproliferative neoplasms, myelodysplastic syndrome, and acute leukemias. Learn more about Dr. Handa: https://cancer.osu.edu/find-a-doctor/search-physician-directory/shivani-handa-100318172.

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to offer trusted information to empower anyone impacted by cancer, through health equity, health literacy and shared decision-making. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/stay-updated/

Видео Developing MPN Research: New Therapies for ET, PV, and Myelofibrosis канала Patient Empowerment Network